REVIVA PHARMACEUTCLS HLDGS INC COM - Stock (TZAC)

CUSIP: G8708A116

Q1 2020 13F Holders as of 31 Mar 2020

Type / Class
Equity / Stock
Total 13F shares
5,456,495
Share change
+1,055,706
Total reported value
$57,395,000
Price per share
$10.52
Number of holders
24
Value change
+$11,148,830
Number of buys
12
Number of sells
11

Quarterly Holders Quick Answers

What is CUSIP G8708A116?
CUSIP G8708A116 identifies TZAC - REVIVA PHARMACEUTCLS HLDGS INC COM - Stock in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of REVIVA PHARMACEUTCLS HLDGS INC COM - Stock (TZAC) as of Q1 2020

As of 31 Mar 2020, REVIVA PHARMACEUTCLS HLDGS INC COM - Stock (TZAC) was held by 24 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 5,456,495 shares. The largest 10 holders included Hudson Bay Capital Management LP, MIZUHO SECURITIES USA LLC, BANK OF MONTREAL /CAN/, BERKLEY W R CORP, GLAZER CAPITAL, LLC, Polar Asset Management Partners Inc., BANK OF AMERICA CORP /DE/, Periscope Capital Inc., Shaolin Capital Management LLC, and Bulldog Investors, LLC. This page lists 24 institutional shareholders reporting positions in this security for the Q1 2020 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.